{"protocolSection":{"identificationModule":{"nctId":"NCT02034058","orgStudyIdInfo":{"id":"WEAVE Trial"},"organization":{"fullName":"Stryker Neurovascular","class":"INDUSTRY"},"briefTitle":"Post Market Surveillance Study of the Wingspan Stent System","officialTitle":"WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study","acronym":"WEAVE"},"statusModule":{"statusVerifiedDate":"2019-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2013-12"},"primaryCompletionDateStruct":{"date":"2019-08","type":"ACTUAL"},"completionDateStruct":{"date":"2019-08","type":"ACTUAL"},"studyFirstSubmitDate":"2014-01-09","studyFirstSubmitQcDate":"2014-01-09","studyFirstPostDateStruct":{"date":"2014-01-13","type":"ESTIMATED"},"resultsFirstSubmitDate":"2019-10-10","resultsFirstSubmitQcDate":"2019-11-27","resultsFirstPostDateStruct":{"date":"2019-12-02","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-11-27","lastUpdatePostDateStruct":{"date":"2019-12-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Stryker Neurovascular","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.","detailedDescription":"This research study is a Food and Drug Administration (FDA) mandated post market surveillance study of the Wingspan® Stent System, also known as the WEAVE™ Trial. The purpose of this trial is to fulfill a FDA requirement to evaluate the rate of stroke and/or death within 72 hours of the procedure, in patients who have a Wingspan Stent implanted in accordance with the Indications for Use."},"conditionsModule":{"conditions":["Intracranial Atherosclerosis"],"keywords":["Wingspan Stent System","Wingspan Stent","Intracranial Stent","Ischemic Stroke","Intracranial Atherosclerotic Disease","Intracranial Stenosis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":152,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Wingspan Stent System","type":"OTHER","description":"Placement of the Wingspan Stent","interventionNames":["Device: Wingspan Stent System"]}],"interventions":[{"type":"DEVICE","name":"Wingspan Stent System","description":"The Wingspan Stent System is used with the Gateway PTA Balloon Catheter. The Wingspan Stent System is a self-expanding, Nitinol stent and delivery system intended for use in the treatment of intracranial atherosclerotic disease. The Gateway PTA Balloon Catheter is an over-the-wire balloon catheter intended for the pre-dilation of the lesion prior to insertion and deployment of the Wingspan Stent System.","armGroupLabels":["Wingspan Stent System"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Rate of Stroke or Death Among Participants","description":"The primary endpoint in this study is the rate of stroke (ischemic or hemorrhagic) or death within 72 hours of the procedure. Ischemic stroke was defined as a neurological deficit that is thought to have an ischemic cause and is detectable on examination at least 24 hours after onset of symptoms. Hemorrhagic stroke was defined as a symptomatic intracerebral, subarachnoid, or primary intraventricular hemorrhage. The type of stroke was confirmed by imaging.","timeFrame":"within 72 hours of the procedure"}],"secondaryOutcomes":[{"measure":"Rate of Ischemic Stroke Among Participants","description":"Ischemic stroke was defined as a neurological deficit that is thought to have an ischemic etiology and is detectable on examination at least 24 hours after onset of symptoms.","timeFrame":"within 72 hours post procedure"},{"measure":"Rate of Neurological Death Among Participants","description":"A diagnosis of death by neurological criteria","timeFrame":"within 72 hours post procedure"},{"measure":"Rate of Stroke Recovery Among Participants","description":"Stroke recovery at 90 days post procedure is defined by return to baseline mRS at Day 90.","timeFrame":"at 90 days post procedure"},{"measure":"Rate of Stroke in the Territory of the Stented Artery Among Participants","description":"Stroke in the vascular territory of the stented artery","timeFrame":"within 72 hours post procedure"}]},"eligibilityModule":{"eligibilityCriteria":"All patients for whom treatment with the Wingspan Stent System is considered.","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Michael J Alexander, M.D.","affiliation":"Cedars-Sinai Medical Center","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Wengui Yu, M.D.","affiliation":"University of California, Irvine","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"University of Alabama-Birmingham","city":"Birmingham","state":"Alabama","zip":"35294","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"Sutter Eden Medical Center","city":"Castro Valley","state":"California","zip":"94546","country":"United States","geoPoint":{"lat":37.6941,"lon":-122.08635}},{"facility":"Southern California Permanente Medical Group","city":"Los Angeles","state":"California","zip":"90027","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Cedars-Sinai Medical Center","city":"Los Angeles","state":"California","zip":"90048","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"UCSD Medical Center","city":"San Diego","state":"California","zip":"92103","country":"United States","geoPoint":{"lat":32.71533,"lon":-117.15726}},{"facility":"Santa Barbara Cottage Hospital","city":"Santa Barbara","state":"California","zip":"93105","country":"United States","geoPoint":{"lat":34.42083,"lon":-119.69819}},{"facility":"Mount Sinai Medical Center","city":"Miami Beach","state":"Florida","zip":"33140","country":"United States","geoPoint":{"lat":25.79065,"lon":-80.13005}},{"facility":"Emory University, Grady Memorial Hospital","city":"Atlanta","state":"Georgia","zip":"30303","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"WellStar Health System","city":"Marietta","state":"Georgia","zip":"30060","country":"United States","geoPoint":{"lat":33.9526,"lon":-84.54993}},{"facility":"University of Chicago","city":"Chicago","state":"Illinois","zip":"60637","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Cadence Health, Northwestern Medicine Central DuPage Hospital","city":"Winfield","state":"Illinois","zip":"60190","country":"United States","geoPoint":{"lat":41.8617,"lon":-88.1609}},{"facility":"Baptist Health Lexington","city":"Lexington","state":"Kentucky","zip":"40503","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"University of Kentucky Medical Center","city":"Lexington","state":"Kentucky","zip":"40536","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"University of Massachusetts, Worcester","city":"Worcester","state":"Massachusetts","zip":"01655","country":"United States","geoPoint":{"lat":42.26259,"lon":-71.80229}},{"facility":"St. John Hospital and Medical Center, Inc.","city":"Detroit","state":"Michigan","zip":"48236","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"SSM DePaul Health Center","city":"Bridgeton","state":"Missouri","zip":"63044","country":"United States","geoPoint":{"lat":38.767,"lon":-90.41151}},{"facility":"Columbia University Medical Center","city":"New York","state":"New York","zip":"10032","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"University Hospital of Cincinnati","city":"Cincinnati","state":"Ohio","zip":"45219","country":"United States","geoPoint":{"lat":39.12713,"lon":-84.51435}},{"facility":"Cleveland Clinic","city":"Cleveland","state":"Ohio","zip":"44195","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"Oregon Health & Science University","city":"Portland","state":"Oregon","zip":"97219","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"Abington Memorial Hospital","city":"Abington","state":"Pennsylvania","zip":"19001","country":"United States","geoPoint":{"lat":40.12067,"lon":-75.11795}},{"facility":"Tennessee Interventional Associates","city":"Chattanooga","state":"Tennessee","zip":"37403","country":"United States","geoPoint":{"lat":35.04563,"lon":-85.30968}},{"facility":"Valley Baptist Harlingen","city":"Harlingen","state":"Texas","zip":"78550","country":"United States","geoPoint":{"lat":26.19063,"lon":-97.6961}},{"facility":"Sentara Norfolk General Hospital","city":"Norfolk","state":"Virginia","zip":"23507","country":"United States","geoPoint":{"lat":36.84681,"lon":-76.28522}},{"facility":"University of Washington, Harborview Medical Center","city":"Seattle","state":"Washington","zip":"98104","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"Multicare Medical Center","city":"Tacoma","state":"Washington","zip":"98405","country":"United States","geoPoint":{"lat":47.25288,"lon":-122.44429}}]},"referencesModule":{"references":[{"pmid":"31125298","type":"DERIVED","citation":"Alexander MJ, Zauner A, Chaloupka JC, Baxter B, Callison RC, Gupta R, Song SS, Yu W; WEAVE Trial Sites and Interventionalists. WEAVE Trial: Final Results in 152 On-Label Patients. Stroke. 2019 Apr;50(4):889-894. doi: 10.1161/STROKEAHA.118.023996."}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","comment":"Study stopped early per pre-defined criteria for interim analysis.","numSubjects":"152"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"149"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"3"}]}],"dropWithdraws":[{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"3"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients who have a Wingspan stent procedure attempted."}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"152"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"61.89","spread":"10.52"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"71"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"81"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Race/Ethnicity","categories":[{"title":"Caucasian","measurements":[{"groupId":"BG000","value":"101"}]},{"title":"African American or Black","measurements":[{"groupId":"BG000","value":"30"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"4"}]},{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"12"}]},{"title":"Multiracial","measurements":[{"groupId":"BG000","value":"5"}]}]}]},{"title":"Baseline modified Rankin Scale","description":"mRS scale is as follows: 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent\" or similar).","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"0","measurements":[{"groupId":"BG000","value":"20"}]},{"title":"1","measurements":[{"groupId":"BG000","value":"37"}]},{"title":"2","measurements":[{"groupId":"BG000","value":"52"}]},{"title":"3","measurements":[{"groupId":"BG000","value":"43"}]},{"title":"4","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"5","measurements":[{"groupId":"BG000","value":"0"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Rate of Stroke or Death Among Participants","description":"The primary endpoint in this study is the rate of stroke (ischemic or hemorrhagic) or death within 72 hours of the procedure. Ischemic stroke was defined as a neurological deficit that is thought to have an ischemic cause and is detectable on examination at least 24 hours after onset of symptoms. Hemorrhagic stroke was defined as a symptomatic intracerebral, subarachnoid, or primary intraventricular hemorrhage. The type of stroke was confirmed by imaging.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"within 72 hours of the procedure","groups":[{"id":"OG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"152"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}]},{"type":"SECONDARY","title":"Rate of Ischemic Stroke Among Participants","description":"Ischemic stroke was defined as a neurological deficit that is thought to have an ischemic etiology and is detectable on examination at least 24 hours after onset of symptoms.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"within 72 hours post procedure","groups":[{"id":"OG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"152"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}]},{"type":"SECONDARY","title":"Rate of Neurological Death Among Participants","description":"A diagnosis of death by neurological criteria","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"within 72 hours post procedure","groups":[{"id":"OG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"152"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}]},{"type":"SECONDARY","title":"Rate of Stroke Recovery Among Participants","description":"Stroke recovery at 90 days post procedure is defined by return to baseline mRS at Day 90.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"at 90 days post procedure","groups":[{"id":"OG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"152"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}]},{"type":"SECONDARY","title":"Rate of Stroke in the Territory of the Stented Artery Among Participants","description":"Stroke in the vascular territory of the stented artery","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"within 72 hours post procedure","groups":[{"id":"OG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"152"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Serious and Other Adverse Events were monitored/assessed for up to 72 hours post-procedure. All-Cause Mortality was monitored/assessed through 90 days post procedure.","description":"Only neurological AEs, bleeding/hemorrhagic AEs (including non-neurological events), groin puncture AEs and AEs that resulted in death experienced by the study subject after enrollment were collected.","eventGroups":[{"id":"EG000","title":"Stenting","description":"Prospective, single-arm, consecutive enrollment, post market surveillance study of patients treated with the Wingspan Stent System, according to the Indications for Use.","deathsNumAffected":3,"deathsNumAtRisk":152,"seriousNumAffected":9,"seriousNumAtRisk":152,"otherNumAffected":12,"otherNumAtRisk":152}],"seriousEvents":[{"term":"Haemorrhagic stroke","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":152}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Neurological decompensation","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Hypertension","organSystem":"Vascular disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]}],"otherEvents":[{"term":"Administration site pain","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":152}]},{"term":"Application site haematoma","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":152}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Headache","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":152}]},{"term":"Muscular weakness","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]},{"term":"Neurological symptom","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":152}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":152}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Alice Lin, Clinical Program Manager","organization":"Stryker Neurovascular","email":"alice.lin@stryker.com","phone":"510 413 2673"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2016-10-13","uploadDate":"2019-10-10T02:37","filename":"Prot_SAP_000.pdf","size":389384}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000002537","term":"Intracranial Arteriosclerosis"},{"id":"D000050197","term":"Atherosclerosis"}],"ancestors":[{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000020765","term":"Intracranial Arterial Diseases"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M25878","name":"Atherosclerosis","asFound":"Atherosclerosis","relevance":"HIGH"},{"id":"M6165","name":"Constriction, Pathologic","relevance":"LOW"},{"id":"M5476","name":"Intracranial Arteriosclerosis","asFound":"Intracranial Atherosclerosis","relevance":"HIGH"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M22211","name":"Intracranial Arterial Diseases","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":true}